RANDOMİZED,DOUBLE-BLİND TRİAL OF EFFECT OF DEXMEDETOMİDİNE AND MİDAZOLAM SEDATİON ON HEART RATE VARİABİLİTY AFTER CORONARY ARTERY BYPASS GRAFT SURGERY
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 14 Nov 2018
Price : $35 *
At a glance
- Drugs Dexmedetomidine (Primary) ; Midazolam (Primary)
- Indications Sedation
- Focus Therapeutic Use
- 01 Nov 2018 Planned End Date changed from 1 Nov 2018 to 1 Dec 2019.
- 01 Nov 2018 Planned primary completion date changed from 1 Oct 2018 to 1 Apr 2019.
- 02 Aug 2018 New trial record